These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36973292)

  • 1. Extracellular vesicles released from ganglioside GD2-expressing melanoma cells enhance the malignant properties of GD2-negative melanomas.
    Yesmin F; Furukawa K; Kambe M; Ohmi Y; Bhuiyan RH; Hasnat MA; Mizutani M; Tajima O; Hashimoto N; Tsuchida A; Kaneko K; Furukawa K
    Sci Rep; 2023 Mar; 13(1):4987. PubMed ID: 36973292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglioside GD2 Enhances the Malignant Phenotypes of Melanoma Cells by Cooperating with Integrins.
    Yesmin F; Bhuiyan RH; Ohmi Y; Yamamoto S; Kaneko K; Ohkawa Y; Zhang P; Hamamura K; Cheung NV; Kotani N; Honke K; Okajima T; Kambe M; Tajima O; Furukawa K; Furukawa K
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential roles of gangliosides in malignant properties of melanomas.
    Ohmi Y; Kambe M; Ohkawa Y; Hamamura K; Tajima O; Takeuchi R; Furukawa K; Furukawa K
    PLoS One; 2018; 13(11):e0206881. PubMed ID: 30462668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disialyl gangliosides enhance tumor phenotypes with differential modalities.
    Furukawa K; Hamamura K; Ohkawa Y; Ohmi Y; Furukawa K
    Glycoconj J; 2012 Dec; 29(8-9):579-84. PubMed ID: 22763744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of malignant properties of human osteosarcoma cells with disialyl gangliosides GD2/GD3.
    Shibuya H; Hamamura K; Hotta H; Matsumoto Y; Nishida Y; Hattori H; Furukawa K; Ueda M; Furukawa K
    Cancer Sci; 2012 Sep; 103(9):1656-64. PubMed ID: 22632091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosignals modulated by tumor-associated carbohydrate antigens: novel targets for cancer therapy.
    Furukawa K; Hamamura K; Aixinjueluo W; Furukawa K
    Ann N Y Acad Sci; 2006 Nov; 1086():185-98. PubMed ID: 17185516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2.
    Iwasawa T; Zhang P; Ohkawa Y; Momota H; Wakabayashi T; Ohmi Y; Bhuiyan RH; Furukawa K; Furukawa K
    Int J Oncol; 2018 Apr; 52(4):1255-1266. PubMed ID: 29436609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Roles of Extracellular Vesicles in Malignant Melanoma.
    Cheng YC; Chang YA; Chen YJ; Sung HM; Bogeski I; Su HL; Hsu YL; Wang HD
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecules in the signaling pathway activated by gangliosides can be targets of therapeutics for malignant melanomas.
    Furukawa K; Hamamura K; Nakashima H; Furukawa K
    Proteomics; 2008 Aug; 8(16):3312-6. PubMed ID: 18690647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gangliosides of human melanoma.
    Tsuchida T; Saxton RE; Morton DL; Irie RF
    J Natl Cancer Inst; 1987 Jan; 78(1):45-54. PubMed ID: 3467129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells--Evidence of unique microRNA cargos.
    Lunavat TR; Cheng L; Kim DK; Bhadury J; Jang SC; Lässer C; Sharples RA; López MD; Nilsson J; Gho YS; Hill AF; Lötvall J
    RNA Biol; 2015; 12(8):810-23. PubMed ID: 26176991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G
    Otake AH; de Freitas Saito R; Duarte APM; Ramos AF; Chammas R
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Mar; 1864(3):422-432. PubMed ID: 29908366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma.
    Niederkorn JY; Mellon J; Pidherney M; Mayhew E; Anand R
    Curr Eye Res; 1993 Apr; 12(4):347-58. PubMed ID: 8319494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Yin and Yang of tumour-derived extracellular vesicles in tumour immunity.
    Yamauchi T; Moroishi T
    J Biochem; 2021 Mar; 169(2):155-161. PubMed ID: 33226400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.
    Hamilton WB; Helling F; Lloyd KO; Livingston PO
    Int J Cancer; 1993 Feb; 53(4):566-73. PubMed ID: 8436430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF
    Lunavat TR; Cheng L; Einarsdottir BO; Olofsson Bagge R; Veppil Muralidharan S; Sharples RA; Lässer C; Gho YS; Hill AF; Nilsson JA; Lötvall J
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5930-E5939. PubMed ID: 28684402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.
    Cheresh DA; Pierschbacher MD; Herzig MA; Mujoo K
    J Cell Biol; 1986 Mar; 102(3):688-96. PubMed ID: 3005335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-to-cell communication: microRNAs as hormones.
    Bayraktar R; Van Roosbroeck K; Calin GA
    Mol Oncol; 2017 Dec; 11(12):1673-1686. PubMed ID: 29024380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretion rates and protein composition of extracellular vesicles released by cancer-associated fibroblasts after radiation.
    Berzaghi R; Islam A; Hellevik T; Martinez-Zubiaurre I
    J Radiat Res; 2021 May; 62(3):401-413. PubMed ID: 33899109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential roles of integrin-mediated signaling for the enhancement of malignant properties of melanomas based on the expression of GD3.
    Ohkawa Y; Miyazaki S; Miyata M; Hamamura K; Furukawa K; Furukawa K
    Biochem Biophys Res Commun; 2008 Aug; 373(1):14-9. PubMed ID: 18538130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.